Glioblastoma multiforme is the most common and aggressive primary brain tumor, with an average survival time after diagnosis of less than two years and for which current treatments remain ineffective. In recent years, immunotherapies have given patients hope, albeit with relatively modest success. A team from the University of Geneva (UNIGE) and the University Hospitals […]
Glioblastoma multiforme is an extremely aggressive brain tumor that is currently incurable. Oncologists can extend the life expectancy of patients with surgery, radiotherapy, chemotherapy, or surgical interventions. However, half of patients die within twelve months of diagnosis. Drugs that are effective against brain tumors are demanding to find because many cancer drugs often can’t cross […]
